REMARC

Communication orale REMARC ICMLugano 2021
Catherine Thieblemont

Defining ultra-high-risk DLBCL patients prior to initial treatment based on an integrative host and disease prognostic score (from REMARC study)

 

ICMLugano Catherine Thieblemont Abstract N°017

 

Posters REMARC ICMLugano 2021
Catherine Thieblemont

Circulating tumor DNA load and total metabolic tumor volume in Diffuse Large B Cell Lymphoma (DLBCL) patients treated by R-CHOP – From REMARC, a LYSA study

 

ICMLugano Catherine Thieblemont Abstract N°091

Catherine Thieblemont

High adipose tissue density is a negative prognostic factor in DLBCL patients treated by R-CHOP, independent from TMTV and PS – From the REMARC study

 

ICMLugano Catherine Thieblemont Abstract N°166